Using vancomycin powder to prevent infections in open fractures in the emergency room
Official title: Placement of Antibiotic Powder in Wounds During the Emergency Room (POWDER) Study
Run by The University of Texas Health Science Center at San Antonio · NCT03765567 · Data updated 2026-11-12
This study tests whether using vancomycin powder directly on open fracture wounds in the emergency room can help prevent infections better than regular IV antibiotics.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | The University of Texas Health Science Center at San Antonio Academic / other |
| Locations | 2 sites (San Antonio, Texas and 1 other locations) |
| Status | Recruiting |
| Started | October 5, 2020 |
| Main results expected | September 2027 |
| Study ends | September 2028 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT03765567 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have sustained an open fracture of specific bones within 24 hours of injury.
✕Probably not a fit
Patients who have received prior operative care for their open fracture or those with documented allergies to vancomycin may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of applying topical vancomycin powder to open fracture wounds in the emergency department to reduce infection-related complications. Open fractures are particularly vulnerable to infections, and traditional systemic IV antibiotics may not adequately reach the affected tissues due to compromised blood supply. By administering vancomycin powder directly to the wound, the study aims to enhance antibiotic delivery and improve patient outcomes. This is the first prospective controlled study of its kind, focusing on the acute treatment of open fractures.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of infections in patients with open fractures, leading to better recovery outcomes.
How similar studies have gone: While this approach is novel in the context of open fractures, similar studies using topical antibiotics have shown promise in other surgical and trauma settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject or Legal Authorized Representative (LAR) is willing and able to provide written informed consent. * Adult 18 years of age or older. * Open fracture of the humerus, radius, ulna, femur, tibia, and/or fibula. * 24 hours or less has elapsed from the estimated time of injury to study intervention. Exclusion Criteria: * Time from injury \> 24 hours. * Subjects who have received acute operative care (e.g., washout in the operating room or fixation) of the open fracture at an outside facility. * Subject or LAR speaks neither English nor Spanish. Note that subjects that are unable to participate in the consent process (e.g. intoxication, poly-trauma, will be enrolled into the observational arm where passive data collection will occur). * High-potency antibiotic powder or solution applied to the wound prior to enrollment. Simple ointment (i.e., bacitracin ointment) or antibiotic-impregnated dressings will be permitted. * Documented allergies or serious reactions to vancomycin. History of uncomplicated "red man syndrome" will not be considered a reason for exclusion. * Pregnant subjects. If the subject is a female of childbearing potential, and she states that she is likely to be pregnant, a pregnancy test will be performed; if negative, the subject will be eligible for enrollment. * Prisoners. * Participation in other clinical research involving investigational antimicrobial products within 30 days of randomization.
Where it's running
-
University Hospital
San Antonio, Texas, United States Recruiting -
San Antonio Military Medical Center
San Antonio, Texas, United States Not yet recruiting
Study contacts
- Principal investigator: Robert A De Lorenzo, MD — University of Texas
- Study coordinator: Robert A De Lorenzo, MD
- Email: DeLorenzo@uthscsa.edu
- Phone: 210-567-0056
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing how much saline to use when washing open fractures
This will test whether using smaller amounts of sterile saline to wash open fractures in adults works as well as using larger amounts.
-
Using light-based imaging for open and infected fractures
This study is testing a new light-based imaging method to see if it can help doctors better diagnose and manage open or infected fractures without using drugs or contrast agents.
-
Rapid relief of suicidal thoughts with ketamine and a crisis plan in the emergency department
This study tests whether a single intramuscular dose of ketamine plus a brief Crisis Response Plan helps reduce suicidal thoughts in ED patients who are likely to be admitted.
-
Aprepitant for CLIFAHDD in young children and adults
This early-phase, safety-focused study tests whether aprepitant can be safely taken daily by people with CLIFAHDD to see if it’s tolerable and may help daily living.
-
Genetics of Skeletal Muscle Insulin Resistance
This study tests how insulin affects gene activity in skeletal muscle by taking muscle samples during a controlled insulin clamp in adults with normal glucose tolerance.
-
Training behavioral health providers to deliver Written Exposure Therapy with web and AI support
This study tests whether web-based training with AI help helps providers learn to deliver Written Exposure Therapy to veterans with PTSD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.